BioCentury | Nov 19, 2020
Emerging Company Profile

Umoja launches with $53M round to test cell therapy cocktails that expand CAR T cells within patients

...an engineered immunotherapy system designed in concert with Phil Low, a professor of chemistry at Purdue University. Instrumental...
...CAR T therapies that can be expanded in vivoOrigin of technology: Seattle Children’s Research Institute, Purdue University...
BioCentury | Nov 7, 2020
Translation in Brief

Neoleukin’s ACE2 decoy protects hamsters from SARS-CoV-2; plus a circular RNA linked to diabetes and more

...components and impaired insulin release.Dual-mechanism compound for flu A and BA bifunctional small molecule synthesized by Purdue University...
...influenza A and B infection.TARGETSACE2 – Angiotensin-converting enzyme 2 Danielle Golovin Relenza, zanamivir (GG167) Neoleukin Therapeutics Inc. University of Lausanne Purdue University Vaxart...
BioCentury | Jan 15, 2019
Distillery Techniques

Drug platforms

...online Dec. 11, 2018 doi:10.1016/j.celrep.2018.11.067 CONTACT: Michael G. Rossmann, Purdue University, West Lafayette, Ind. email: mr@purdue.edu Jennie Walters Purdue University Eastern...
BioCentury | Dec 11, 2018
Distillery Therapeutics

Cancer

...online Nov. 27, 2018 doi:10.1158/0008-5472.CAN-18-1834 CONTACT: Philip S. Low, Purdue University, West Lafayette, Ind. email: plow@purdue.edu Claire Quang Purdue University Carbonic...
BioCentury | Oct 18, 2018
Distillery Therapeutics

Dermatology

...H. Leung, University of Pennsylvania School of Medicine, Philadelphia, Pa. email: thl@pennmedicine.upenn.edu Jaime De Leon Mozobil, plerixafor (AMD3100) Purdue University Chemokine...
BioCentury | May 23, 2018
Distillery Therapeutics

Cancer

...26, 2018 doi:10.1158/0008-5472.CAN-17-3006 CONTACT: Xiaoqi Liu, Purdue University, West Lafayette, Ind. email: liu8@purdue.edu Mark Zipkin Xtandi, enzalutamide (mdv3100, p-INN) Purdue University Beta-catenin...
BioCentury | May 16, 2018
Politics & Policy

NIH to increase cryo-electron microscopy access

...Technology, Purdue University, University of Utah and Yale University. Allison Johnson California Institute of Technology NIH Oregon Health & Science University Purdue University Stanford...
BioCentury | Nov 9, 2017
Finance

The return of big

...& Johnson each announced two. One of the Lilly deals, a $52 million collaboration with Purdue University...
...long-term master service agreements at universities. In July, it announced its first such partnership with Purdue University...
...Osaka, Japan National Institutes of Health (NIH), Bethesda, Md. Navire Pharma Inc., Palo Alto, Calif. Purdue University...
BioCentury | Nov 6, 2017
Financial News

Exicure raises additional $11.2M in private placement

...to treat psoriasis are due this year (see BioCentury Extra, Dec. 12. 2016) . Jennie Walters AST-005 Exicure Inc. Purdue University Tumor...
BioCentury | Sep 21, 2017
Translation in Brief

No vehicle, no problem

...A Purdue University team has developed a ligand-targeted method to deliver microRNA (miRNA) mimics to tumors without...
...the field that says you can't do that, because RNA will be degraded." Andrea Kasinski, Purdue University...
...cancers that express different cell surface receptors, such as prostate-specific antigen ( PSA ; KLK3). Purdue University...
Items per page:
1 - 10 of 84
BioCentury | Nov 19, 2020
Emerging Company Profile

Umoja launches with $53M round to test cell therapy cocktails that expand CAR T cells within patients

...an engineered immunotherapy system designed in concert with Phil Low, a professor of chemistry at Purdue University. Instrumental...
...CAR T therapies that can be expanded in vivoOrigin of technology: Seattle Children’s Research Institute, Purdue University...
BioCentury | Nov 7, 2020
Translation in Brief

Neoleukin’s ACE2 decoy protects hamsters from SARS-CoV-2; plus a circular RNA linked to diabetes and more

...components and impaired insulin release.Dual-mechanism compound for flu A and BA bifunctional small molecule synthesized by Purdue University...
...influenza A and B infection.TARGETSACE2 – Angiotensin-converting enzyme 2 Danielle Golovin Relenza, zanamivir (GG167) Neoleukin Therapeutics Inc. University of Lausanne Purdue University Vaxart...
BioCentury | Jan 15, 2019
Distillery Techniques

Drug platforms

...online Dec. 11, 2018 doi:10.1016/j.celrep.2018.11.067 CONTACT: Michael G. Rossmann, Purdue University, West Lafayette, Ind. email: mr@purdue.edu Jennie Walters Purdue University Eastern...
BioCentury | Dec 11, 2018
Distillery Therapeutics

Cancer

...online Nov. 27, 2018 doi:10.1158/0008-5472.CAN-18-1834 CONTACT: Philip S. Low, Purdue University, West Lafayette, Ind. email: plow@purdue.edu Claire Quang Purdue University Carbonic...
BioCentury | Oct 18, 2018
Distillery Therapeutics

Dermatology

...H. Leung, University of Pennsylvania School of Medicine, Philadelphia, Pa. email: thl@pennmedicine.upenn.edu Jaime De Leon Mozobil, plerixafor (AMD3100) Purdue University Chemokine...
BioCentury | May 23, 2018
Distillery Therapeutics

Cancer

...26, 2018 doi:10.1158/0008-5472.CAN-17-3006 CONTACT: Xiaoqi Liu, Purdue University, West Lafayette, Ind. email: liu8@purdue.edu Mark Zipkin Xtandi, enzalutamide (mdv3100, p-INN) Purdue University Beta-catenin...
BioCentury | May 16, 2018
Politics & Policy

NIH to increase cryo-electron microscopy access

...Technology, Purdue University, University of Utah and Yale University. Allison Johnson California Institute of Technology NIH Oregon Health & Science University Purdue University Stanford...
BioCentury | Nov 9, 2017
Finance

The return of big

...& Johnson each announced two. One of the Lilly deals, a $52 million collaboration with Purdue University...
...long-term master service agreements at universities. In July, it announced its first such partnership with Purdue University...
...Osaka, Japan National Institutes of Health (NIH), Bethesda, Md. Navire Pharma Inc., Palo Alto, Calif. Purdue University...
BioCentury | Nov 6, 2017
Financial News

Exicure raises additional $11.2M in private placement

...to treat psoriasis are due this year (see BioCentury Extra, Dec. 12. 2016) . Jennie Walters AST-005 Exicure Inc. Purdue University Tumor...
BioCentury | Sep 21, 2017
Translation in Brief

No vehicle, no problem

...A Purdue University team has developed a ligand-targeted method to deliver microRNA (miRNA) mimics to tumors without...
...the field that says you can't do that, because RNA will be degraded." Andrea Kasinski, Purdue University...
...cancers that express different cell surface receptors, such as prostate-specific antigen ( PSA ; KLK3). Purdue University...
Items per page:
1 - 10 of 84